Exact Sciences (EXAS) Surpasses Q2 Earnings and Revenue Estimates

Exact Sciences (EXAS) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to a loss of $0.09 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +1,200.00%. A quarter ago, it was expected that this molecular diagnostics company would post a loss of $0.37 per share when it actually produced a loss of $0.21, delivering a surprise of +43.24%.Over the la ...